Lung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked. A new study, led by researchers at Washington University School of ...

Pancreatic cancer is among the most aggressive and feared types of cancer. The disease often causes no clear symptoms for a ...

In a recent study, Stevens researchers have shown how colorectal cancers can evolve from mature intestinal cells that revert ...

Lung cancer remains the world’s deadliest cancer, and cigarette smoke is its chief culprit. Chemicals in tobacco, such as polycyclic aromatic hydrocarbons (PAHs), damage DNA and trigger the mutations ...

TP53 mutations are crucial in cancer development and treatment response, influenced by genetic and environmental factors. In CLL and AML, TP53 serves as a significant prognostic marker, affecting ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...

For years, scientists described the genetics of feline cancer as something of a mystery. While dogs have become increasingly ...

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove ...